Genflow Biosciences plc (LON:GENF – Get Free Report) shares shot up 2.4% during trading on Friday . The company traded as high as GBX 2.10 and last traded at GBX 2.10. 139,341 shares changed hands during trading, a decline of 95% from the average session volume of 2,580,581 shares. The stock had previously closed at GBX 2.05.
Genflow Biosciences Stock Performance
The business’s 50-day moving average price is GBX 2.18 and its 200 day moving average price is GBX 1.99. The stock has a market capitalization of £11.25 million, a PE ratio of -6.33 and a beta of 2.11.
Genflow Biosciences (LON:GENF – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported GBX (0.33) EPS for the quarter. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Featured Articles
- Five stocks we like better than Genflow Biosciences
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
